Skip to main content
. Author manuscript; available in PMC: 2016 Oct 19.
Published in final edited form as: Arthritis Rheumatol. 2016 Oct;68(10):2361–2371. doi: 10.1002/art.39748

Figure 3.

Figure 3

Results from the ASTIS trial comparing CD4+ 34 selected autologous HSCT after conditioning with CYC and ATG compared with results after 12 months CYC (controls). Left panel, event-free survival (survival free of organ failure). Right panel, overall survival (31).